ADAS-Jcog
Showing 1 - 25 of 72
Alzheimer, Early Onset Trial in Japan (LIPUS-Brain, Placebo)
Not yet recruiting
- Alzheimer Disease, Early Onset
- LIPUS-Brain
- Placebo
-
Nagoya, Aichi, Japan
- +11 more
Aug 1, 2023
Alzheimer 3, Epilepsy Trial in Changsha (Lacosamide 100 mg, Levetiracetam 250mg)
Recruiting
- Alzheimer Disease 3
- Epilepsy
- Lacosamide 100 mg
- Levetiracetam 250mg
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Aug 2, 2023
Parkinson Disease Trial in Gainesville (PD Drivers Using AV Technologies On-road)
Recruiting
- Parkinson Disease
- PD Drivers Using AV Technologies On-road
-
Gainesville, FloridaUF Norman Fixel Institute for Neurological Diseases
Mar 23, 2022
Mild Cognitive Impairment, Prodromal Alzheimer's Disease Trial (AGB101, Placebo)
Not yet recruiting
- Mild Cognitive Impairment
- Prodromal Alzheimer's Disease
- AGB101
- Placebo
- (no location specified)
Aug 3, 2023
Alzheimer's Disease Trial (Piromelatine 20 mg, Placebo)
Not yet recruiting
- Alzheimer's Disease
- Piromelatine 20 mg
- Placebo
- (no location specified)
Mar 3, 2022
Respiratory Tract Infection, Respiratory Syncytial Virus Trial in Worldwide (MK-1654, Placebo)
Completed
- Respiratory Tract Infection
- Respiratory Syncytial Virus
- Clesrovimab
- Placebo
-
Aurora, Colorado
- +33 more
Sep 25, 2022
Mild Cognitive Impairment Trial in Quezon (INDAK (Improving Neurocognition through Dance and Kinesthetics), Nutrition
Completed
- Mild Cognitive Impairment
- INDAK (Improving Neurocognition through Dance and Kinesthetics)
- +2 more
-
Quezon, Metro Manila, PhilippinesInstitute for Neurosciences, St. Luke's Medical Center
Oct 26, 2022
COVID-19 Trial in Harrow (AZD7442, Placebo)
Completed
- COVID-19
- AZD7442
- Placebo
-
Harrow, United KingdomResearch Site
Oct 26, 2021
Mild Cognitive Impairment, Alzheimer Trial in Sacramento, Walnut Creek (Senicapoc, Placebo Tablet)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Senicapoc
- Placebo Tablet
-
Sacramento, California
- +1 more
Mar 23, 2022
Brain Metastases, Radiotherapy Side Effect, Cognitive Impairment Trial in Guangzhou (Monosialotetrahexosyl ganglioside (GM1),
Recruiting
- Brain Metastases
- +4 more
- Monosialotetrahexosyl ganglioside (GM1)
- Control
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 3, 2021
Alzheimer's Disease Trial in Busan (Alfoatirin® Tab. + Aripezil® Tab., Aripezil® Tab.)
Active, not recruiting
- Alzheimer's Disease
- Alfoatirin® Tab. + Aripezil® Tab.
- Aripezil® Tab.
-
Busan, Korea, Republic of
- +5 more
Dec 20, 2020
Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (BIIB037)
- Placebo
-
Phoenix, Arizona
- +180 more
Aug 9, 2021
Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (BIIB037)
- Placebo
-
Birmingham, Alabama
- +179 more
Aug 9, 2021
Osteoarthritis of the Knee, Pain Trial in Worldwide (REGN5069, Matching Placebo)
Terminated
- Osteoarthritis of the Knee
- Pain
- REGN5069
- Matching Placebo
-
DeLand, Florida
- +11 more
Jun 10, 2021
COVID-19 Virus Disease Trial in Roma, Verona (MAD0004J08, Placebo)
Completed
- COVID-19 Virus Disease
- MAD0004J08
- Placebo
-
Roma, Lazio, Italy
- +1 more
Apr 26, 2022
Alzheimer Trial in Seoul (Donepezil patch, aricept Tab)
Completed
- Alzheimer Disease
- Donepezil patch
- aricept Tab
-
Seoul, Korea, Republic of46 Sites including Konkuk University Medical Center
Feb 10, 2021
Parkinson Disease, Driving Impaired Trial in London (Lane change assistance system, Active Control)
Recruiting
- Parkinson Disease
- Driving Impaired
- Lane change assistance system
- Active Control
-
London, Ontario, CanadaUniversity of Western Ontario
Apr 5, 2021